Skip to main content
. Author manuscript; available in PMC: 2016 Oct 25.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2013;53:557–580. doi: 10.1146/annurev-pharmtox-010510-100456

Table 1.

Binding affinity assays and biological assays of penicillamine-containing cyclic enkephalins

Compound Binding affinity assays Biological assays
vs[3H]DADLE
δ (nM)
vs[3H]naloxone
μ (nM)
MVD
(nM)
GPI (nM)
c[D-Pen2,Cys5]enka 11.7 178 0.32 213
c[D-Pen2,D-Cys]enka 26 157 6.3 1,350
c[D-Pen2,Cys5]enk-NH2a 3.4 73 3.6 118
c[D-Pen2,D-Cys5]enk-NH2a 7.2 162 16.8 117
c[D-Pen2,D-Pen5]enk (DPDPE) 1.6 610 4.1 7,300
[2S,3S]TMT1-DPDPE 211 720 170 290
[2S,3R]TMT1-DPDPE 5.0 4,300 1.8 0% at 60 μM (antagonist)
[2R,3S]TMT1-DPDPE 9% at 10 μM 0% at 10 μM 28% at 10 μM 75% at 10 μM
[2R,3R]TMT1-DPDPE 3,500 77,000 2,200 75% at 82 μM
a

Data taken from Reference 29.

Abbreviations: DADLE, [D-Ala2,D-Leu5]enkephalin; DPDPE, c[D-Pen2,D-Pen5]enkephalin; enk, enkephalin; GPI, guinea pig ileum; MVD, mouse vas deferens; TMT, β-methyl-2′,6′-dimethyltyrosine (trimethyltyrosine).